Stigma of Substance Use Disorder Varies by Condition, Provider
By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 30, 2025 -- Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in Addiction.
Carrigan L. Parish, Ph.D., from the Columbia Mailman School of Public Health in New York City, and colleagues quantified the prevalence and intensity of provider stigma toward patients with SUD by substance use type and compared with other conditions using a national probability sample survey, conducted from October 2020 to October 2022. Data were obtained from 1,240 randomly selected primary care physicians (PCPs) and emergency medicine physicians (EMPs) and dentists.
The researchers found the lowest stigma rating for diabetes and the highest for stimulant use disorders (mean, 23.2 and 36.3, respectively). Significantly higher stigma was seen toward opioid use disorder versus alcohol use disorder (effect size, 0.49), while stigma toward stimulant use disorders was significantly higher than toward opioid use disorder (effect size, 0.11). Significantly higher stigma scores were seen for EMPs than PCPs, while stigma scores were significantly higher for PCPs than dentists. There was an association for lower stigma scores with provision of SUD referrals (effect size, −0.37), providing medications (effect sizes, −0.44, −1.26, and −0.73 for alcohol, opioid, and stimulant use disorder, respectively), and having available SUD consultation (effect sizes, −0.48, −0.51, and −0.59 for alcohol, opioid, and stimulant use disorders, respectively).
"Our findings show that many providers still feel uncomfortable treating patients with substance use disorders and that hesitancy leads directly to missed opportunities for care," Parish said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-31 06:00
Read more

- Americans Braced For Loss Of Gender-Affirming Care
- Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma
- GLP-1 Drugs Increase Risk Of Acid Reflux, GERD
- Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
- Specific Antiseizure Medications Associated With Major Malformations in Infants
- Regular Sexual Activity Linked to Fewer Genitourinary-Related Symptoms in Menopause
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions